Aims: To explore the common effects of the clusterin (CLU) rs11136000 variant on the default mode network (DMN) in amnestic mild cognitive impairment (aMCI) subjects and remitted geriatric depression (RGD) subjects.
our recent cross-sectional study did not find any impact of the CLU rs11136000 variant on the DMN itself in either healthy elderly subjects or subjects with amnestic mild cognitive impairment (aMCI, an intermediate state between normal aging and early AD that is characterized by episodic memory loss). 10 The reasons may include the limited sample size and the multiple regions-of-interest-based methods used in DMN reconstruction, both of which may reduce the sensitivity of DMN alterations.
Both aMCI and geriatric depression are very common in the elderly population and confer an increased risk for developing AD. 11 A high prevalence of depressive symptoms has been found among MCI patients, 12 and cognitive impairments are also common in depressed patients. 13 The coexistence of aMCI and depression significantly increase the risk for AD. 14 Furthermore, increased Aβ deposition has been shown not only in aMCI patients but also in geriatric depression patients. 15, 16 As described above, increased Aβ deposition may induce aberrant DMN changes, and thus, DMN patterns have been investigated in MCI patients and geriatric depression patients. For example, both decreased FC from the posterior to anterior portions of DMN and increased FC with multiple brain regions have been identified in MCI patients. [17] [18] [19] Similarly, both decreased DMN FC with the frontal cortex and increased FC with the parietal cortex and the anterior cingulate cortex have been found in geriatric depression patients.
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However, whether the DMN patterns in these subjects can be regulated by the CLU gene remains relatively unknown. This study hypothesized that the CLU gene could affect the DMN patterns in both aMCI subjects and geriatric depression subjects. In addition, in view of the distinct clinical link between MCI and geriatric depression, we also hypothesized that similar effects of the CLU gene on the DMN might exist between aMCI subjects and geriatric depression subjects.
This study recruited cognitively normal elderly subjects, aMCI subjects, and remitted geriatric depression (RGD) subjects. Each group was divided into CLU-CC carriers and CLU-CT/TT carriers. All subjects underwent resting-state fMRI scans and neuropsychological tests at both baseline and a 35-month follow-up. A series of quantitative DMN FC analyses were performed. The aims of this study were (i) to explore the effects of the CLU rs11136000 variant on the longitudinal changing patterns of the DMN in aMCI, RGD, and cognitively normal elderly subjects; (ii) to determine whether aMCI and RGD share a common regulation of the DMN by the CLU; and (iii) to identify the behavioral significance of CLU gene-related modulation of the DMN.
| METHODS

| Participants
This study was approved by the Affiliated ZhongDa Hospital of Southeast University Research Ethics Committee. Chinese Han participants were recruited using community health screening and media advertisements. Written informed consent was provided by each participant. We initially recruited 87 aMCI subjects, 72 RGD subjects, and 135 cognitively normal elderly subjects. During the follow-up period, 36 aMCI subjects and 34 RGD subjects were lost due to the development of neurological or other psychiatric diseases, relocation to other cities, passing by, nonresponders, and subjective unwillingness. The follow-ups of cognitively normal elderly subjects were paused after comparative numbers of aMCI subjects, RGD subjects, and cognitively normal elderly subjects were obtained. A total of 51 aMCI subjects, 38 RGD subjects, and 64 cognitively normal elderly subjects underwent resting-state fMRI scans and neuropsychological tests at both baseline and follow-up. The mean follow-up period was 35 months. Eight aMCI subjects, five RGD subjects, and four cognitively normal elderly subjects were excluded after the evaluation of head motion artifacts. During the follow-up period, six aMCI subjects converted to cognitively normal elderly subjects and nine cognitively normal elderly subjects converted to aMCI subjects. These subjects were also excluded to decrease the heterogeneity in each group.
Finally, there were 37 aMCI subjects, 33 RGD subjects, and 51 control subjects. In the remaining RGD subjects, the average age of onset of depression was 60±9.43 years, and 28 subjects developed depression after the age of 50 years, also known as late-onset depression.
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These groups were matched for the duration of the follow-up period.
| Neuropsychological assessments
Each subject underwent a standardized diagnostic evaluation, including demographic information, medical history, and examination of neurological and mental status. See Supporting information.
| Inclusion and exclusion criteria
All aMCI subjects were included according to the diagnostic criteria proposed by Petersen et al. 23 and others. 24 The inclusion criteria for RGD subjects and control subjects were described previously. 25 See
Supporting information.
| CLU genotyping
See Supporting information. In consideration of a dominant model of minor T allele effects, 26, 27 each group was divided into CLU-CC carriers and CLU-CT/TT carriers.
| Magnetic resonance imaging procedures and image preprocessing
See Supporting information. Because the global signal has recently been thought to be related to major neuronal components, the global signal was not regressed in the present study. 
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| FC analysis
| Group-level intrinsic connectivity analysis
To analyze the interaction between the CLU genotype, disease, and The significance level for post hoc tests was set at P<.05. It should be noted that ANCOVA was performed in aMCI subjects (aMCI vs control) and RGD subjects (RGD vs control) respectively. Then, the overlaps and nonoverlaps between the interactive regions in aMCI and RGD subjects were further analyzed.
| Correlative analysis between FC alterations and episodic memory impairments
Correlation analyses were performed between the longitudinal changes of FC in each interactive region and the longitudinal changes in episodic memory scores in each group. It should be noted that the correlative analysis was focused on episodic memory for the following reasons.
First, in the present study, episodic memory was the most impaired cognitive domain in both aMCI and RGD subjects. Second, many studies have suggested that episodic memory is subserved by the DMN. 
| RESULTS
| Demographic and neuropsychological data
As shown in Table 1 , compared with control subjects, RGD subjects had less years of education. No other significant difference was observed in the demographic characteristics or the ApoE status between all groups. A significant main effect of disease was shown in the neuropsychological data. Compared with control subjects, both aMCI subjects and RGD subjects displayed impairments in all cognitive domains, except the information processing speed for RGD subjects. Compared with aMCI subjects, RGD subjects displayed poorer performance in all cognitive domains except for visuospatial function. A main effect of the CLU gene was also shown. CLU-CC carriers exhibited poorer performance in information processing speed than CLU-CT/TT carriers.
Furthermore, a main effect of time revealed longitudinal decreases in MMSE and executive function scores in the whole sample during the follow-up period. There was no significant interaction of disease, CLU gene, and time on neuropsychological data (data on interactions of any two factors were not shown). Finally, it should be noted that although some subjects were excluded during analyses, there was no significant demographic difference between included subjects and excluded subjects (Table S1 ).
| DMN FC data
The main effects of CLU gene, disease, and time are shown in Figures S1 and S2. While comparing aMCI subjects and control subjects, the CLU gene×disease×time interaction was detected in the frontal cortex, parietal cortex, and cingulate cortex, most of which belong to the core cortical midline structures of the DMN ( Figure 1A ). While comparing RGD subjects and control subjects, the CLU gene×disease×time interaction was primarily observed in the limbic regions and small parts of cerebral cortex ( Figure 1B) . Specifically, the overlaps between the interactive regions in aMCI subjects and those in RGD subjects were found in the left middle frontal gyrus (LMFG) and the left medial orbital frontal gyrus (LMOFG; Figure 1C and Table 2 ).
Post hoc test: For each overlapping region, no significant difference in FC at baseline or FC changes during follow-up were shown between control subjects, aMCI subjects, and RGD subjects (Table   S2 ). Then, these three groups were divided into six subgroups according to the CLU genotype. The six subgroups displayed no significant difference in FC at baseline but did exhibit a significant difference of FC changes during follow-up (Table 3) . CLU-CT/TT carriers in both the aMCI group and the RGD group displayed significant longitudinally decreased FC ( Figures S3 and S4 ).
| Longitudinal changes of DMN FC and behavioral significance
As shown in Table 4 
| DISCUSSION
The present study is the first to show the effects of the CLU gene on the DMN in subjects at high risk of AD. Some adjustments were made relative to our previous study. First, PCC seed-based FC analysis was used to obtain DMN patterns. The PCC is a key region of the DMN, and the PCC seed-based FC analysis has been widely used in DMN construction. 31 Second, the present study employed longitudinal data from a larger sample size. One of the key strengths of the present study was that this study employed two different groups of subjects at high risk of AD. Despite the different core symptoms of aMCI subjects and RGD subjects, both displayed impaired performance in multiple cognitive domains. Differences and similarities were also found in the DMN patterns. The CLU gene×disease×time interaction for aMCI subjects was mainly detected in the core cortical midline structures of Values are presented as the mean±standard deviation (SD). ANOVA was applied in each comparison. The overlaps between the interactive regions in aMCI subjects and in RGD subjects appear in bold.
T A B L E 2 Gene×disease×time interaction on DMN
the DMN, and the interaction in RGD subjects was mainly detected in the limbic system. However, the interactive regions of the two groups overlapped in frontal regions, suggesting that the CLU gene could consistently affect the DMN changing patterns in the frontal cortex among subjects at high risk of AD. Interestingly, using DTI, common deficits of structural connectivity patterns between aMCI and RGD patients were also shown in frontal regions in our previous study.
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These data indicate that the frontal lobe plays an important role in the neural underpinnings of aMCI and RGD.
The other strength of the present work was that the participants were followed for an average of nearly 3 years. As the most important risk factor for AD, 34 aging could affect the DMN patterns at different stages of the disease. For example, aging-related decreases of the DMN FC have been widely reported in cognitively normal elderly subjects. 35, 36 At the stage of MCI, both aging-related decreases of DMN FC in the frontal cortex and increases in the prefrontal cortex and the anterior cingulate cortex have been shown. 37 Moreover, the aging-related changes of DMN FC, including increases in the frontal cortex and decreases in major parts of the network, were accelerated in subjects with AD. 36 The present study also found both longitudinally increased DMN FC primarily in frontal regions and decreased FC in extensive regions. Notably, within the two disease groups, all of the significantly increased FC was shown in CLU-CC carriers, and all of the decreased FC with significances was shown in CLU-CT/TT carriers.
The CLU gene-related distribution suggested that the increased FC in frontal regions tends to occur in subjects at a much higher risk of AD, that is, with both CLU-CC genotype and aMCI or RGD. On the other hand, disease groups with a protective factor, that is, the CLU-T allele, tended to display extensively decreased DMN FC.
Increased fMRI activity and FC in the frontal cortex have been generally considered as compensatory recruitment or reallocation of cognitive resources because they have been associated with relatively better performance in cognitive tasks. 38 However, several studies found that increased activity and FC were associated with relatively worse performance. 39, 40 One study demonstrated that the reduction of brain activities could even improve cognitive function in aMCI patients. 39 Another study found that reduced resting-state FC was associated with increased task-related activity, which could compensate to maintain cognitive performance. 41 In the present study, for CLU-CT/ TT carriers, both the increased FC with frontal regions in the control group and the decreased FC with parietal and limbic regions in the aMCI and RGD groups compensated for episodic memory declines.
We concluded that the effects of FC changes in episodic memory depended not only on the FC changing patterns, that is, increases or decreases, but also on the risk factors associated with each subject, including the disease status and the CLU rs11136000 variant; Thus far, no study has explored the interaction of geriatric depression and the CLU gene on the incidence of dementia. However, the present study found that geriatric depression interacted with the CLU gene to affect the changing patterns in the DMN. Importantly, the interaction between geriatric depression and the CLU gene was highly similar to that between aMCI and the CLU gene in the frontal cortex.
Even in the nonoverlapping regions, CLU gene-related changing trends of DMN FC were also similar between aMCI and RGD subjects. In summary, geriatric depression could interact with the CLU gene to result in aMCI-like alterations of the DMN. The interactive effects might be associated with Aβ pathology. Increased brain Aβ deposition has been shown in geriatric depression patients compared with healthy elderly. 16 Healthy elderly with depressive episodes also display high Aβ deposition. 42 Subjects with both geriatric depression and MCI even had Aβ deposition comparable to that in AD. 43 On the other hand, CLU gene could also modulate the brain Aβ loads. 44 Therefore, the coexistence of geriatric depression and CLU risk variants might considerably influence Aβ pathology, which could be reflected by the DMN patterns. Future studies investigating the interaction of geriatric depression and the CLU gene on the incidence of AD will help to confirm these synergistic effects.
The present study has several limitations. First, the sample size was small, especially for testing three-way interactions. During the follow-up period, nine subjects in the control group converted to aMCI subjects and nine subjects in the aMCI group converted to dementia subjects. However, the small number of converters limited further analyses comparing alterations of the DMN between converters and nonconverters. Second, although the interaction of geriatric depression and the CLU gene was interpreted based on Aβ pathology, the present study did not utilize any techniques to measure Aβ pathology.
Finally, in the post hoc tests, comparisons between subgroups or time points were not corrected for multiple comparisons. Thus, these interpretations should be treated with caution.
| CONCLUSION
The CLU rs11136000 variant could consistently affect the changing of DMN patterns of aMCI and RGD subjects in the frontal cortex.
The CLU-T allele was associated with more compensatory neural processes in DMN changes. The findings may help to focus attention to the frontal cortex when investigating the effects of the CLU gene on the brain. The interaction of the CLU gene and the diagnosis should be considered in future studies. Furthermore, the present findings also indicate that the CLU gene might interact with geriatric depression and be related to risk of developing AD, which should be investigated in the future.
